References
- Notelovitz M. Urogenital ageing: solutions in clinical practice. Int J Gynaecol Obstet 1997; 59 (suppl 1): S35–9.
- Heimer G, Samsioe G. Effects of vaginally delivered estrogens. Acta Obstet Gynecol Scand 1996; 75 (suppl. 163): 12.
- Milsom I, Arvidsson L, Ekelund P, Molander U, Eriksson O. Factors influencing vaginal cytology, pH and bacterial flora in elderly women. Acta Obstet Gynecol Scand 1993; 74(4): 286–91.
- Ravnikar VA. Barriers for taking long-term hormone replacement therapy: Why do women not adhere to therapy? Eur Menopause J 1996; 3 (suppl): 90–3.
- Mattsson L-Å, Cullberg G, Eriksson O, Knutsson F Vaginal administration of low-dose estradiol – effects on the endometrium and vaginal cytology. Maturitas 1989; 11: 217–22.
- Calaf Alsina J. Perception and use of local hormone replacement therapy. Eur J Menopause 1996; 3 (suppl): 859.
- Bachmann GA. Urogenital ageing: An old problem newly recognized. Maturitas 1995; 22 (suppl): 1–5.
- Larsen S, Sandvik L, Osnes M. The sample size in multicentre and stratified designed trials. Pharm Med 1991; 5: 97–105.
- Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993; 329: 753–6.
- Handa VL, Bachus KE, Johnston WW, Robboy SJ, Hammond CB. Vaginal administration of low-dose conjugated estrogens: systemic absorption and effects on the endometrium. Obstet Gynecol 1994; 84: 215–18.
- Devlin MC, Rioux JE, Gelfand MM, Steinberg WM, Hepburn DS, Nanavati N. Vagifem™ vs Premarin® vaginal cream: efficacy and safety in women with estrogen deficiency-derived atrophic vaginitis. Menopause 1998; 5: 257.
- Mettler L, Olsen PG. Long-term treatment of atrophic vaginitis with low-dose estradiol vaginal tablets. Maturitas 1991; 14: 23–31.
- Eriksen RS, Rasmussen H. Low-dose 17 β-estradiol vaginal tablets in the treatment of atrophic vaginitis: a double-blind placebo controlled study. Eur J Obstet Gynecol Reprod Biol 1992; 44: 137–44.
- Bachmann G, Notelovitz M, Nanavati N, Mazzeo M. Safety and efficacy of a low-dose estrogen intravaginal tablet (VagifemTM) to treat estrogen-deficiency derived atrophic vaginitis. Menopause 1998; 5 (abstract): 256.
- Bachmann G, Notelovitz M, Nanavati N, Mazzeo M. Long-term safety and efficacy of Vagifem in the treatment of estrogen deficiency derived atrophic vaginitis. Menopause 1998; 5 (abstract): 256.
- Notelovitz M, Funk S, Nanavati N, Mazzeo M. Systemic absorption of 17 β-estradiol (E2) during treatment with vaginal E2 10 μg and Vagifem™ 25 μg tablets. Menopause 1998; 5 (abstract): 256.